The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-07-25
DOI
10.1002/jlb.ma1217-495r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations
- (2017) Fenghuang Xu et al. IMMUNOLOGIC RESEARCH
- Dual Roles of IL-27 in Cancer Biology and Immunotherapy
- (2017) Marina Fabbi et al. MEDIATORS OF INFLAMMATION
- Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity
- (2017) Jeongsu Do et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
- (2017) Alessandra Dondero et al. Oncotarget
- IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm
- (2017) James P. White Translational Cancer Research
- Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
- (2017) Kristine Pettersen et al. Scientific Reports
- Interleukin-30 Promotes Breast Cancer Growth and Progression
- (2016) Irma Airoldi et al. CANCER RESEARCH
- An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
- (2016) Hasita Horlad et al. CANCER SCIENCE
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
- (2016) Thomas R. Flint et al. Cell Metabolism
- Combinatorial immunotherapy strategies for hepatocellular carcinoma
- (2016) Maria Tagliamonte et al. CURRENT OPINION IN IMMUNOLOGY
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells
- (2016) Xiaotong Zhu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
- (2016) Lewis Zhichang Shi et al. Nature Communications
- Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
- (2016) Andrea Petretto et al. Oncotarget
- Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
- (2015) James J. Harding et al. CANCER
- Potential clinical application of interleukin-27 as an antitumor agent
- (2015) Takayuki Yoshimoto et al. CANCER SCIENCE
- Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
- (2015) Christelle Bahlawane et al. Cell Communication and Signaling
- The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity
- (2015) Samadhi Aparicio-Siegmund et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
- (2015) Charles E. Egwuagu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity
- (2015) Kiyoshi Hirahara et al. IMMUNITY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
- (2015) Claire Vanpouille-Box et al. VACCINE
- IL-27 induces the expression of IDO and PD-L1 in human cancer cells
- (2015) Grazia Carbotti et al. Oncotarget
- FactoMineR: AnRPackage for Multivariate Analysis
- (2015) Sébastien Lê et al. Journal of Statistical Software
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- STAT3 Is Indispensable to IL-27-Mediated Cell Proliferation but Not to IL-27-Induced Th1 Differentiation and Suppression of Proinflammatory Cytokine Production
- (2014) T. Owaki et al. JOURNAL OF IMMUNOLOGY
- Antiproliferative Activity of IL-27 on Melanoma
- (2014) T. Yoshimoto et al. JOURNAL OF IMMUNOLOGY
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Role of interleukin-6 in cachexia
- (2014) Aditi A. Narsale et al. Current Opinion in Supportive and Palliative Care
- Interleukin-30 Expression in Prostate Cancer and Its Draining Lymph Nodes Correlates with Advanced Grade and Stage
- (2013) Serena Di Meo et al. CLINICAL CANCER RESEARCH
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas
- (2013) Julie Gonin et al. PLoS One
- IL-27 in tumor immunity and immunotherapy
- (2013) Gopal Murugaiyan et al. TRENDS IN MOLECULAR MEDICINE
- Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
- (2013) Alexander Swarbrick et al. OncoImmunology
- Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
- (2012) Kiyoshi Hirahara et al. IMMUNITY
- An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer
- (2012) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-27 Production and STAT3-Dependent Upregulation of B7-H1 Mediate Immune Regulatory Functions of Liver Plasmacytoid Dendritic Cells
- (2012) B. M. Matta et al. JOURNAL OF IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunomodulatory cytokines as therapeutic agents for melanoma
- (2011) Courtney Nicholas et al. Immunotherapy
- IL-27 renders DC immunosuppressive by induction of B7-H1
- (2011) Svetlana Karakhanova et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
- (2010) F. Toffalini et al. BLOOD
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Interleukin-27 acts on hepatic stellate cells and induces signal transducer and activator of transcription 1-dependent responses
- (2010) Caroline Schoenherr et al. Cell Communication and Signaling
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
- (2009) M. Matsui et al. CANCER RESEARCH
- Interleukin-27 displays interferon-γ-like functions in human hepatoma cells and hepatocytes
- (2009) Herdis Bender et al. HEPATOLOGY
- Hypoxia-inducible factor 1α is up-regulated by oncostatin M and participates in oncostatin M signaling
- (2009) Stefan Vollmer et al. HEPATOLOGY
- Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
- (2009) R. Salcedo et al. JOURNAL OF IMMUNOLOGY
- The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling
- (2009) S. Crabe et al. JOURNAL OF IMMUNOLOGY
- Interleukin 27: a double-edged sword for offense and defense
- (2009) Hiroki Yoshida et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
- (2009) Peng Hu et al. MOLECULAR IMMUNOLOGY
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
- (2008) R. R. Weichselbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-27-Mediated Activation of Natural Killer Cells and Inflammation Produced Antitumour Effects for Human Oesophageal Carcinoma Cells
- (2008) L. Liu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started